Skip to main content

Advertisement

SpringerLink
Log in

Metabolic Health Index (MHI): Assessment of Comorbidity in Bariatric Patients Based on Biomarkers

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Purpose

The focus of bariatric surgery is reduction of weight, reflected in body mass index (BMI). However, the resolution of comorbidity is a second important outcome indicator. The degree of comorbidity is hard to quantify objectively as comorbidities develop gradually and are interdependent. Multiple scoring systems quantifying comorbidity exist but they lack continuity and objectivity. In analogy with BMI as index for weight, the Metabolic Health Index (MHI) is developed as objective quantification of metabolic health status. Laboratory data were used as comorbidities affect biomarkers. Conversely, laboratory data can be used as objectively obtained variables to describe comorbidity.

Methods

Laboratory data were collected and crosschecked by national quality registry entries. Machine learning was applied to develop an ordinal logistic regression model, using 4 clinical and 32 laboratory input variables. The output was mathematically transformed into a continuous score for intuitive interpretation, ranging from 1 to 6 (MHI).

Results

In total, 4778 data records of 1595 patients were used. The degree of comorbidity is best described by age at phlebotomy, estimated Glomerular Filtration Rate (eGFR), and concentrations of glycated hemoglobin (HbA1c), triglycerides, and potassium. The model is independent of day of sampling and type of surgery. Mean MHI was significantly different between patient subgroups with increasing number of comorbidities.

Conclusion

The MHI reflects severity of comorbidity, enabling objective assessment of a bariatric patient’s metabolic health state, regardless day of sampling and surgery type. Next to weight-focused outcome measures like %TWL, the MHI can serve as outcome measure for metabolic health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384(9945):766–81.

    Article  Google Scholar 

  2. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.

    Article  CAS  Google Scholar 

  3. The GBD 2015 Obesity Collaborators, Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.

  4. Frühbeck G. Bariatric and metabolic surgery: a shift in eligibility and success criteria. Nat Rev Endocrinol. 2015;11(8):465–77.

    Article  Google Scholar 

  5. Sjöholm K, Anveden Å, Peltonen M, et al. Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish Obese Subjects (SOS) study. Diabetes Care. 2013;36(5):1335–40.

    Article  Google Scholar 

  6. Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:1–21.

    Google Scholar 

  7. Adams TD, Davidson LE, Litwin SE, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377(12):1143–55.

    Article  Google Scholar 

  8. Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24(1):42–55.

    Article  CAS  Google Scholar 

  9. Monteiro R, and Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. vol. 2010, Article ID 289645, 10 pages, 2010. https://doi.org/10.1155/2010/289645

    Article  Google Scholar 

  10. Han TS, and Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis. 2016;5 https://doi.org/10.1177/2048004016633371

    Article  Google Scholar 

  11. O’Neill S, Bohl M, Gregersen S, et al. Blood-based biomarkers for metabolic syndrome. Trends Endocrinol Metab. 2016;27(6):363–74.

    Article  Google Scholar 

  12. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The Lancet. 2005;365(9468):1415–28.

    Article  CAS  Google Scholar 

  13. Sikaris KA. The clinical biochemistry of obesity. Clin Biochem Rev. 2004;25(3):165–81.

    PubMed  PubMed Central  Google Scholar 

  14. Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. The Lancet. 2005;366(9491):1059–62.

    Article  Google Scholar 

  15. Eckel RH, Alberti K, Grundy SM, et al. The metabolic syndrome. The Lancet. 2010;375(9710):181–3.

    Article  Google Scholar 

  16. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes. 2009;33(3):289–95.

    Article  CAS  Google Scholar 

  17. Gill RS, Karmali S, Sharma AM. The potential role of the Edmonton obesity staging system in determining indications for bariatric surgery. Obes Surg. 2011;21(12):1947–9.

    Article  Google Scholar 

  18. DeBoer MD, Gurka MJ. Clinical utility of metabolic syndrome severity scores: considerations for practitioners. Diabetes Metab Syndr Obes Targets Ther. 2017;10:65–72.

    Article  CAS  Google Scholar 

  19. Cubeddu LX, Hoffmann IS. Metabolic syndrome: an all or none or a continuum load of risk? Metab Syndr Relat Disord. 2011;10(1):14–9.

    Article  Google Scholar 

  20. Wijndaele K, Beunen G, Duvigneaud N, et al. A continuous metabolic syndrome risk score. Diabetes Care. 2006;29(10):2329.

    Article  Google Scholar 

  21. Soldatovic I, Vukovic R, Culafic D, et al. siMS Score: simple method for quantifying metabolic syndrome. PLOS ONE. 2016;11(1):e0146143.

    Article  Google Scholar 

  22. Wiley JF, Carrington MJ. A metabolic syndrome severity score: a tool to quantify cardio-metabolic risk factors. Prev Med. 2016;88:189–95.

    Article  Google Scholar 

  23. Harrell FE. Regression modeling strategies. 2nd ed. Switzerland: Springer International Publishing; 2015.

  24. R Core. Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical. Computing. 2019

  25. Poelemeijer YQ, Liem RS, Nienhuijs SW. A Dutch nationwide bariatric quality registry: DATO. Obes Surg. 2018;28(6):1602-10.

    Article  Google Scholar 

  26. James G, Witten D, Hastie T, Tibshirani R. An introduction to statistical learning - with applications in R. 1st ed. New York; Springer-Verlag; 2013 

    Google Scholar 

  27. Steyerberg E. Clinical prediction models - a practical approach to development. 1st ed. New York: Springer-Verlag; 2009.

  28. Rothman MJ, Rothman SI, Beals J. Development and validation of a continuous measure of patient condition using the electronic medical record. J Biomed Inform. 2013;46(5):837–48.

    Article  Google Scholar 

  29. Cohen DD, Gómez-Arbeláez D, Camacho PA, et al. Low muscle strength is associated with metabolic risk factors in Colombian children: the ACFIES study. PLoS ONE. 2014;9(4):e93150

    Article  Google Scholar 

  30. Kim J, Tanabe K, Yokoyama N, et al. Association between physical activity and metabolic syndrome in middle-aged Japanese: a cross-sectional study. BMC Public Health. 2011;11:624.

    Article  Google Scholar 

  31. Ekblom Ö, Ekblom-Bak E, Rosengren A, et al. Cardiorespiratory fitness, sedentary behaviour and physical activity are independently associated with the metabolic syndrome, results from the SCAPIS pilot study. PLOS ONE. 2015;10(6):e0131586.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Edwin R. van den Heuvel (Prof) from the Eindhoven University of Technology for providing his insight and expertise that greatly assisted the research. In addition, we thank Carmen Gensen for her assistance in the data analysis process.

Author information

Authors and Affiliations

  1. Department of Clinical Chemistry, Catharina Hospital, P.O. Box 1350, 5602, ZA, Eindhoven, The Netherlands

    Saskia L. M. van Loon, Ruben Deneer, Volkher Scharnhorst & Arjen-Kars Boer

  2. Department of Industrial Engineering and Innovation Sciences, Eindhoven University of Technology, Eindhoven, The Netherlands

    Saskia L. M. van Loon, Anna Wilbik & Uzay Kaymak

  3. Expert Center Clinical Chemistry, Eindhoven, The Netherlands

    Saskia L. M. van Loon, Ruben Deneer, Volkher Scharnhorst & Arjen-Kars Boer

  4. Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands

    Ruben Deneer, Natal van Riel, Volkher Scharnhorst & Arjen-Kars Boer

  5. Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands

    Simon W. Nienhuijs

Authors
  1. Saskia L. M. van Loon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruben Deneer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Simon W. Nienhuijs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anna Wilbik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Uzay Kaymak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Natal van Riel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Volkher Scharnhorst
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Arjen-Kars Boer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saskia L. M. van Loon.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Ethical Approval

For this type of study formal consent is not required.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1.

(PPTX 238 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van Loon, S.L.M., Deneer, R., Nienhuijs, S.W. et al. Metabolic Health Index (MHI): Assessment of Comorbidity in Bariatric Patients Based on Biomarkers. OBES SURG 30, 714–724 (2020). https://doi.org/10.1007/s11695-019-04244-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-019-04244-1

Keywords

Search

Navigation